4 CheckMate-037: Höhere objektive Ansprechrate unter Nivolumab im Vergleich zur Chemotherapie auch bei Ipilimumab-vorbehandelten Patienten [7]
German derma 2-5
This site is only for use by healthcare professionals. By continuing to view this site you are confirming that you are a healthcare professional.